IBM Identifies Seven Key Pharma Technologies

From IBM Pharma 2010: Executive Strategy Reports:

"The molecular sciences will ultimately enable the pharmaceutical industry (Pharma) to change the very nature of the medicines it makes. But if the industry is to capitalize on the understanding of disease that is now starting to emerge, it will have to invest in new tools. This paper identifies the seven key technologies that IBM believes will drive innovation in the life sciences over the next decade. All seven technologies once belonged in the realm of science fiction, but they are fast becoming fact -- the 'silicon reality' to which the title of our report refers."

For additional information about IBM's vision for the future of life sciences follow this About.com link